Panacea Biotec share news, announcements and annual reports
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Panacea Biotec Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹313.25down ₹12.65 (3.88%)BSE ₹312.95
Share price at the NSE close on 30 Oct 2026. Previous close ₹325.90.
30 Oct: open ₹323.05, high ₹325.95, low ₹311.10
52-week range of traded prices to 30 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,919 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.30
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 57,86658.2% delivered
Panacea Biotec orders, deals and press releases
118 filed, newest first. Page 3 of 3.
Oct 2008
1 Oct · Business
Panacea Biotec Ltd. has informed the Exchange regarding the press release dated October 01, 2008, titled "Panacea Biotec enters into Strategic Alliance with PharmAthene, US in Biodefense and Emerging Infectious Diseases. Panacea Biotec to make a US $13.1 Million Strategic Investment in PharmAthene, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2008
12 Aug · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated August 12, 2008, titled "Panacea Biotec bags Award (USD 34.2 million) for Pentavalent Vaccine EasyFive* from UNICEF". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
28 Jul · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated July 28, 2008, titled "Panacea Biotec reports unaudited financial results for the Quarter ended June 30, 2008". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Jul · Business
Panacea Biotec Ltd. has informed the Exchange that: "The Company has received WHO prequalification for its fully liquid innovative combination Pentavalent vaccine, EasyFive against five deadly infectious diseases (DTwP+ Hep B+ Hib) of early childhood. This feat comes close on heels of the Company's pre-qualification by WHO for two other combination vaccines, EasyFour (DTP + Hib) and Ecovac (DTP + Hep B) in January this year. In a notification, WHO has advised the UN procuring agencies regarding the acceptability of these vaccines world-wide". Further, the Company has submitted to the Exchange a copy of the press release in this regard, dated July 10, 2008, titled "Panacea Biotec pre-qualified by WHO for supply of Pentavalent Vaccine, EasyFive* to UN agencies". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Jul · Business
Panacea Biotec Ltd. has informed the Exchange regarding the press release dated July 09, 2008, titled "Panacea Biotec receives US Patent for 'Thank God' ".A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Jul · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated July 04, 2008, titled "Panacea Biotec forays into Healthcare Delivery - Enters collaboration to set-up 220 bed multi super-specialty hospital in NCR". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2008
26 Jun · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated June 26, 2008, titled "Panacea Biotec reports audited financial results for the Quarter and Financial Year Ended March 31, 2008". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
11 Feb · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated February 11, 2008, titled "Panacea Biotec inaugurates GRAND-fifth R&D Centre at Navi Mumbai". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
24 Jan · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated January 24, 2008, titled "Panacea Biotec reports unaudited financial results for the Quarter and nine months ended December 31, 2007". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Jan · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated January 04, 2008, titled "WHO pre- qualifies Panacea Biotec for supply of EasyFour and Ecovac Vaccines". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
23 Oct · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated October 23, 2007, titled "Panacea Biotec reports financial results for the Quarter and Half Year ended September 30, 2007". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Oct · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated October 10, 2007, titled "Panacea Biotec signs an MoU with Panjab University to develop New Chemical Entities". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Oct · Business
Panacea Biotec Ltd. has informed the Exchange that: "The Company has entered into a Memorandum of Agreement (MOA) with Family Vaccines, Philippines to provide access to value added combination vaccines under the umbrella of "Easy Vaccines" manufactured by the Company, to the people in Philippines through a chain of 50 immunization clinics, run by Family Vaccines". Further, a copy of a press release in this regard, dated October 04, 2007, titled "Panacea Biotec signs agreement with Family Vaccines to supply combination vaccines in Philippines" shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2007
25 Sep · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated September 25, 2007, titled "Panacea Biotec inaugurates Vaccine Formulation Plant (VFP) on their Annual Day at Baddi, unveils its new Corporate Identity". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
24 Jul · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated July 24, 2007, titled "Panacea Biotec reports consistent financial results for the Quarter ended June 30, 2007". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2007
28 Jun · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated June 28, 2007, titled "Panacea Biotec forays into Cancer treatment". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Jun · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated June 14, 2007, titled "Panacea Biotec reports 140.9% rise in net profit For financial year ended March 31, 2007 Net Turnover up by 55.0%. EBIDTA surges by 86.3%". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2007
18 Jan · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated January 18, 2007, titled "Panacea Biotec reports Excellent Financial Results for Quarter & Nine Months Ended December 31, 2006-Turnover up by 79% & Net profit surges by 422% in Q3". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.